Open Access

Potential of lactylation as a therapeutic target in cancer treatment (Review)

  • Authors:
    • Zhengfeng Zhu
    • Xinzhe Zheng
    • Pengfei Zhao
    • Cheng Chen
    • Gang Xu
    • Xixian Ke
  • View Affiliations

  • Published online on: February 7, 2025     https://doi.org/10.3892/mmr.2025.13456
  • Article Number: 91
  • Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Post‑translational modifications (PTMs) of proteins influence their functionality by altering the structure of precursor proteins. These modifications are closely linked to tumor progression through the regulation of processes such as cell proliferation, apoptosis, angiogenesis and invasion. Tumors produce large amounts of lactic acid through aerobic glycolysis. Lactic acid not only serves an important role in cell metabolism, but also serves an important role in cell communication. Lactylation, a PTM involving lactate and lysine residues as substrates, serves as an epigenetic regulator that modulates intracellular signaling, gene expression and protein function, thereby serving a crucial role in tumorigenesis and progression. The identification of lactylation provides a key breakthrough in elucidating the interaction between tumor metabolic reprogramming and epigenetic modification. The present review primarily summarizes the occurrence of lactylation, its effect on tumor progression, drug resistance, the tumor microenvironment and gut microbiota, and its potential as a therapeutic target for cancer. The aim of the present review was to provide novel strategies for potential cancer therapies.
View Figures
View References

Related Articles

Journal Cover

April-2025
Volume 31 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu Z, Zheng X, Zhao P, Chen C, Xu G and Ke X: Potential of lactylation as a therapeutic target in cancer treatment (Review). Mol Med Rep 31: 91, 2025.
APA
Zhu, Z., Zheng, X., Zhao, P., Chen, C., Xu, G., & Ke, X. (2025). Potential of lactylation as a therapeutic target in cancer treatment (Review). Molecular Medicine Reports, 31, 91. https://doi.org/10.3892/mmr.2025.13456
MLA
Zhu, Z., Zheng, X., Zhao, P., Chen, C., Xu, G., Ke, X."Potential of lactylation as a therapeutic target in cancer treatment (Review)". Molecular Medicine Reports 31.4 (2025): 91.
Chicago
Zhu, Z., Zheng, X., Zhao, P., Chen, C., Xu, G., Ke, X."Potential of lactylation as a therapeutic target in cancer treatment (Review)". Molecular Medicine Reports 31, no. 4 (2025): 91. https://doi.org/10.3892/mmr.2025.13456